Adage Capital Partners GP L.L.C. Boosts Holdings in The Cooper Companies, Inc. $COO

Key Points

• Adage Capital Partners GP L.L.C. increased its stake in The Cooper Companies by 111.7% in Q1, holding approximately 182,160 shares valued at $15.4 million at quarter's end.
• Multiple institutional investors, including Goldman Sachs and Nuveen, have also expanded their positions in The Cooper Companies, reflecting a growing interest among institutional investors in the stock.
• Analysts maintain a "Moderate Buy" average rating for the stock, with a target price of approximately $86.64, despite some firms recently adjusting their price targets downward.

Adage Capital Partners GP L.L.C. boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 111.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 182,160 shares of the medical device company's stock after purchasing an additional 96,100 shares during the period. Adage Capital Partners GP L.L.C. owned about 0.09% of Cooper Companies worth $15,365,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Zions Bancorporation National Association UT bought a new position in Cooper Companies during the 1st quarter valued at about $33,000. City Holding Co. bought a new position in Cooper Companies during the 1st quarter valued at about $34,000. GKV Capital Management Co. Inc. bought a new position in Cooper Companies during the 1st quarter valued at about $40,000. Larson Financial Group LLC grew its holdings in Cooper Companies by 1,071.0% during the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock valued at $61,000 after purchasing an additional 664 shares during the last quarter. Finally, HM Payson & Co. boosted its position in Cooper Companies by 147.4% in the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock valued at $75,000 after buying an additional 532 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Wall Street Zen cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Mizuho lowered their price objective on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research report on Wednesday, July 16th. Loop Capital set a $100.00 price objective on shares of Cooper Companies in a research report on Tuesday, June 17th. Wells Fargo & Company lowered their price objective on shares of Cooper Companies from $93.00 to $72.00 and set an "overweight" rating for the company in a research report on Thursday, August 28th. Finally, Stifel Nicolaus lowered their price objective on shares of Cooper Companies from $90.00 to $85.00 and set a "buy" rating for the company in a research report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat, Cooper Companies currently has an average rating of "Moderate Buy" and an average target price of $86.64.

Cooper Companies Stock Down 0.7%

NASDAQ:COO traded down $0.50 during midday trading on Wednesday, reaching $67.76. 1,445,870 shares of the stock traded hands, compared to its average volume of 2,297,728. The stock has a market capitalization of $13.47 billion, a PE ratio of 33.41, a price-to-earnings-growth ratio of 1.74 and a beta of 0.97. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $112.38. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12. The business has a 50-day moving average of $71.85 and a two-hundred day moving average of $76.37.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.07 by $0.03. The firm had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The business's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Insider Activity at Cooper Companies

In related news, CEO Albert G. White III acquired 10,000 shares of the firm's stock in a transaction that occurred on Friday, September 5th. The stock was purchased at an average cost of $68.39 per share, with a total value of $683,900.00. Following the transaction, the chief executive officer directly owned 226,151 shares of the company's stock, valued at $15,466,466.89. This trade represents a 4.63% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Daniel G. Mcbride bought 3,000 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The stock was bought at an average price of $65.04 per share, with a total value of $195,120.00. Following the completion of the purchase, the chief operating officer directly owned 63,120 shares in the company, valued at $4,105,324.80. This represents a 4.99% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have bought 15,975 shares of company stock worth $1,079,566. 1.98% of the stock is owned by insiders.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.